Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

PURPOSE: Aromatase inhibitors (AIs) are effective for treatment of hormone receptor–positive breast cancer, but adherence and persistence with therapy are poor. Predictors of treatment discontinuation are not clearly defined. It is unknown whether patients with intolerable toxicity from one AI are a...

詳細記述

保存先:
書誌詳細
主要な著者: Henry, N. Lynn, Azzouz, Faouzi, Desta, Zereunesay, Li, Lang, Nguyen, Anne T., Lemler, Suzanne, Hayden, Jill, Tarpinian, Karineh, Yakim, Elizabeth, Flockhart, David A., Stearns, Vered, Hayes, Daniel F., Storniolo, Anna Maria
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2012
主題:
Original Reports
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341106/
https://ncbi.nlm.nih.gov/pubmed/22331951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.38.0261
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料